Other possible factors contributing to long-term remission beyond drug sensitivity include host immunity against residual leukemia41, which may be more activated in certain subtypes like DUX4 because of greater immunogenicity of the neoantigens in these leukemia cells. The gene discussed is DUX4; the disease is leukemia.